enGene Holdings Inc.
ENGNNASDAQHealthcare● Active
$1.65
+$0.01(+0.61%)
Market Cap$84471712
P/E Ratio—
52W High$12.25
52W Low$1.4
enGene Holdings Inc.（ENGN）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ENGN · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-10 | 2024-10 | 2023-10 | 2022-10 | 2021-10 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.19B | $0.24B | $0.08B | $0.00B | $0.00B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.20B | $0.25B | $0.09B | $0.00B | $0.00B |
| PP&E Net | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.22B | $0.31B | $0.09B | $0.13B | $0.13B |
| Liabilities | |||||
| Short-Term Debt | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.03B | $0.01B | $0.01B | $0.00B | $0.00B |
| Long-Term Debt | $0.02B | $0.02B | $0.01B | $0.00B | $0.00B |
| Total Liabilities | $0.05B | $0.04B | $0.01B | $0.00B | $0.00B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.37B) | ($0.25B) | ($0.20B) | ($0.00B) | ($0.00B) |
| Total Stockholders Equity | $0.17B | $0.27B | $0.07B | $0.13B | $0.13B |
| Total Liab & Equity(computed) | $0.22B | $0.31B | $0.09B | $0.13B | $0.13B |
| Debt Summary | |||||
| Total Debt | $0.03B | $0.03B | $0.01B | $0.00B | $0.00B |
| Net Debt | ($0.02B) | ($0.15B) | ($0.07B) | ($0.00B) | ($0.00B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解enGene Holdings Inc.
关于enGene Holdings Inc.（ENGN）资产负债表
enGene Holdings Inc.总资产$0.22B，现金及短期投资$0.19B，总负债$0.05B，总债务$0.03B，股东权益$0.17B。
常见问题
ENGN · 4 问enGene Holdings Inc.总债务$0.03B，净债务($0.02B)。
ENGN total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10